Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors

Lung cancer is the main cancer killer in both men and women, mostly due to the rapid development of drug resistant metastatic disease. Here, we evaluate the potential involvement of SRC family kinases (SFK) in lung cancer biology and assess the possible benefits of their inhibition as a therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupniewska, Ewa, Roy, Rajat, Mauri, Francesco A., Liu, Xinxue, Kaliszczak, Maciej, Bellezza, Guido, Cagini, Lucio, Barbareschi, Mattia, Ferrero, Stefano, Tommasi, Anna M., Aboagye, Eric, Seckl, Michael J., Pardo, Olivier E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007948/
https://www.ncbi.nlm.nih.gov/pubmed/29937990
http://dx.doi.org/10.18632/oncotarget.25213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007948/
https://www.ncbi.nlm.nih.gov/pubmed/29937990
http://dx.doi.org/10.18632/oncotarget.25213

Ejemplares similares